SCPHARMACEUTICALS INC (SCPH) Stock Analyst Earnings Estimates
NASDAQ:SCPH - Nasdaq - US8106481059 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 13.593M | 36.967M 171.96% | 85.091M 130.18% | 169.67M 99.40% | 254.67M 50.10% | 289.12M 13.53% | 355.63M 23.00% | 423.01M 18.95% | 560.54M 32.51% | 594.92M 6.13% | |||
| EBITDA YoY % growth | -25.79M 13.75% | -36.12M -40.05% | -54.77M -51.63% | -61.251M -11.83% | -44.319M 27.64% | 2.652M 105.98% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -25.82M 13.73% | -36.16M -40.05% | -55.396M -53.20% | -66.116M -19.35% | -42.717M 35.39% | 19.129M 144.78% | 69.81M 264.94% | 116.65M 67.10% | 165.81M 42.14% | 217.21M 31.00% | 333.62M 53.59% | 359.09M 7.63% | |
| Operating Margin | N/A | N/A | -407.53% | -178.85% | -50.20% | 11.27% | 27.41% | 40.35% | 46.62% | 51.35% | 59.52% | 60.36% | |
| EPS YoY % growth | -1.03 21.97% | -1.30 -26.21% | -1.42 -9.23% | -1.97 -39.06% | -0.99 49.89% | 0.27 127.42% | 1.57 478.95% | 2.00 27.27% | 2.87 43.62% | 3.72 29.66% | 4.23 13.70% | 4.64 9.64% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.39 -10.26% | -0.31 14.06% | -0.27 39.73% | -0.23 69.17% | -0.14 64.76% |
| Revenue Q2Q % growth | 12.368M 102.89% | 14.212M 132.91% | 18.258M 126.69% | 22.304M 122.46% | 29.308M 136.97% |
| EBITDA Q2Q % growth | -14.994M 1.57% | -12.75M 19.33% | -10.914M 23.83% | -8.874M 50.86% | -6.12M 59.18% |
| EBIT Q2Q % growth | -16.726M -9.63% | -15.81M 0.29% | -11.618M 19.49% | -8.843M 51.27% | -3.672M 78.05% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.75 -82.93% | -0.30 | -0.45 | -147.99% |
| Q2 2024 Q2Q % growth | -0.44 -22.22% | -0.42 | -0.02 | -4.20% |
| Q1 2024 Q2Q % growth | -0.36 -20.00% | -0.45 | 0.09 | 19.24% |
| Q4 2023 Q2Q % growth | -0.35 -16.67% | -0.43 | 0.08 | 18.07% |
| Q3 2023 Q2Q % growth | -0.41 -10.81% | -0.37 | -0.04 | -10.18% |
| Q2 2023 Q2Q % growth | -0.36 -2.86% | -0.38 | 0.02 | 5.23% |
| Q1 2023 Q2Q % growth | -0.30 -7.14% | -0.37 | 0.07 | 19.42% |
| Q4 2022 Q2Q % growth | -0.30 -11.11% | -0.39 | 0.09 | 24.00% |
| Q3 2022 Q2Q % growth | -0.37 -54.17% | -0.39 | 0.02 | 5.16% |
| Q2 2022 Q2Q % growth | -0.35 -34.62% | -0.31 | -0.04 | -13.12% |
| Q1 2022 Q2Q % growth | -0.28 -7.69% | -0.32 | 0.04 | 11.45% |
| Q4 2021 Q2Q % growth | -0.27 3.57% | -0.35 | 0.08 | 22.90% |
| Q3 2021 Q2Q % growth | -0.24 27.27% | -0.32 | 0.08 | 24.91% |
| Q2 2021 Q2Q % growth | -0.26 27.78% | -0.31 | 0.05 | 15.03% |
| Q1 2021 Q2Q % growth | -0.26 25.71% | -0.31 | 0.05 | 15.03% |
| Q4 2020 Q2Q % growth | -0.28 51.72% | -0.37 | 0.09 | 24.45% |
| Q3 2020 Q2Q % growth | -0.33 | -0.39 | 0.06 | 15.42% |
| Q2 2020 Q2Q % growth | -0.36 7.69% | -0.43 | 0.07 | 16.46% |
| Q1 2020 Q2Q % growth | -0.35 25.53% | -0.55 | 0.20 | 36.16% |
| Q4 2019 Q2Q % growth | -0.58 | -0.54 | -0.04 | -8.31% |
| Q3 2019 Q2Q % growth | -0.33 | -0.46 | 0.13 | 27.70% |
| Q2 2019 Q2Q % growth | -0.39 | -0.50 | 0.11 | 21.43% |
| Q1 2019 Q2Q % growth | -0.47 | -0.53 | 0.06 | 10.82% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 10.026M 164.12% | 11.017M | -991K | -9.00% |
| Q2 2024 Q2Q % growth | 8.054M 391.70% | 8.129M | -75K | -0.92% |
| Q1 2024 Q2Q % growth | 6.102M 195.78% | 6.097M | 5K | 0.08% |
| Q4 2023 Q2Q % growth | 6.096M | 5.636M | 460K | 8.16% |
| Q3 2023 Q2Q % growth | 3.796M | 3.459M | 337K | 9.74% |
| Q2 2023 Q2Q % growth | 1.638M | 1.65M | -12K | -0.73% |
| Q1 2023 Q2Q % growth | 2.063M | 1.394M | 669K | 47.99% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -11.82% | 0% | -24.49% |
| Revenue | 0% | -2.35% | -0.11% | -0.79% |